GO:0010388 | cullin deneddylation | 9.97e-05 | 9.74e-01 | 7.005 | 2 | 4 | 8 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.71e-04 | 1.00e+00 | 6.099 | 2 | 4 | 15 |
GO:0008180 | COP9 signalosome | 9.65e-04 | 1.00e+00 | 5.421 | 2 | 6 | 24 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0032272 | negative regulation of protein polymerization | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0003743 | translation initiation factor activity | 2.29e-03 | 1.00e+00 | 4.796 | 2 | 8 | 37 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0051716 | cellular response to stimulus | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0006684 | sphingomyelin metabolic process | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0009798 | axis specification | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 2 | 3 |
GO:0030375 | thyroid hormone receptor coactivator activity | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0004767 | sphingomyelin phosphodiesterase activity | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0019887 | protein kinase regulator activity | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 2 | 3 |
GO:0045292 | mRNA cis splicing, via spliceosome | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 2 | 4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 2 | 4 |
GO:0008308 | voltage-gated anion channel activity | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0016779 | nucleotidyltransferase activity | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:0015288 | porin activity | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0031274 | positive regulation of pseudopodium assembly | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0030858 | positive regulation of epithelial cell differentiation | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0006820 | anion transport | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 6 |
GO:0045670 | regulation of osteoclast differentiation | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0030877 | beta-catenin destruction complex | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:2000273 | positive regulation of receptor activity | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0031116 | positive regulation of microtubule polymerization | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0005845 | mRNA cap binding complex | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0045667 | regulation of osteoblast differentiation | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 2 | 8 |
GO:0031122 | cytoplasmic microtubule organization | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010390 | histone monoubiquitination | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 2 | 8 |
GO:0046930 | pore complex | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0008285 | negative regulation of cell proliferation | 1.56e-02 | 1.00e+00 | 2.477 | 3 | 11 | 277 |
GO:0006413 | translational initiation | 1.56e-02 | 1.00e+00 | 3.376 | 2 | 6 | 99 |
GO:0045295 | gamma-catenin binding | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0010225 | response to UV-C | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:0032886 | regulation of microtubule-based process | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0044295 | axonal growth cone | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0006379 | mRNA cleavage | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0005095 | GTPase inhibitor activity | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 10 |
GO:0009416 | response to light stimulus | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 10 |
GO:0043409 | negative regulation of MAPK cascade | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 4 | 11 |
GO:0051010 | microtubule plus-end binding | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 2 | 11 |
GO:0007026 | negative regulation of microtubule depolymerization | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 2 | 11 |
GO:0046716 | muscle cell cellular homeostasis | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 1 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 1 | 11 |
GO:0006974 | cellular response to DNA damage stimulus | 2.27e-02 | 1.00e+00 | 3.087 | 2 | 11 | 121 |
GO:0051276 | chromosome organization | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 12 |
GO:0004527 | exonuclease activity | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 4 | 12 |
GO:0035371 | microtubule plus-end | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 2 | 13 |
GO:0010906 | regulation of glucose metabolic process | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 13 |
GO:0008156 | negative regulation of DNA replication | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 13 |
GO:0044070 | regulation of anion transport | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 1 | 14 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 2 | 14 |
GO:0016922 | ligand-dependent nuclear receptor binding | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 2 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 15 |
GO:0014003 | oligodendrocyte development | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 15 |
GO:0000281 | mitotic cytokinesis | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 3 | 15 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 1 | 16 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 2 | 16 |
GO:0009954 | proximal/distal pattern formation | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 2 | 17 |
GO:0009953 | dorsal/ventral pattern formation | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 18 |
GO:0031047 | gene silencing by RNA | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 18 |
GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 1 | 18 |
GO:0035257 | nuclear hormone receptor binding | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 1 | 18 |
GO:0001701 | in utero embryonic development | 3.55e-02 | 1.00e+00 | 2.739 | 2 | 7 | 154 |
GO:0016573 | histone acetylation | 3.64e-02 | 1.00e+00 | 4.758 | 1 | 1 | 19 |
GO:0006913 | nucleocytoplasmic transport | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0045296 | cadherin binding | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 20 |
GO:0001942 | hair follicle development | 4.01e-02 | 1.00e+00 | 4.613 | 1 | 2 | 21 |
GO:0051781 | positive regulation of cell division | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 2 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 1 | 22 |
GO:0006687 | glycosphingolipid metabolic process | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 1 | 22 |
GO:0005737 | cytoplasm | 4.54e-02 | 1.00e+00 | 0.813 | 9 | 127 | 2633 |
GO:0005881 | cytoplasmic microtubule | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 3 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 5 | 24 |
GO:0006412 | translation | 4.61e-02 | 1.00e+00 | 2.530 | 2 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 4.66e-02 | 1.00e+00 | 2.522 | 2 | 17 | 179 |
GO:0005902 | microvillus | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 1 | 25 |
GO:0048538 | thymus development | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 1 | 25 |
GO:0005913 | cell-cell adherens junction | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 3 | 25 |
GO:0007094 | mitotic spindle assembly checkpoint | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 4 | 25 |
GO:0009267 | cellular response to starvation | 4.94e-02 | 1.00e+00 | 4.305 | 1 | 1 | 26 |
GO:0033077 | T cell differentiation in thymus | 4.94e-02 | 1.00e+00 | 4.305 | 1 | 2 | 26 |
GO:0045785 | positive regulation of cell adhesion | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 3 | 29 |
GO:0070830 | tight junction assembly | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 1 | 29 |
GO:0006446 | regulation of translational initiation | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 2 | 29 |
GO:0005743 | mitochondrial inner membrane | 5.53e-02 | 1.00e+00 | 2.383 | 2 | 9 | 197 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 3 | 30 |
GO:0004402 | histone acetyltransferase activity | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 3 | 30 |
GO:0009408 | response to heat | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 1 | 31 |
GO:0042645 | mitochondrial nucleoid | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 1 | 31 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 6 | 31 |
GO:0016328 | lateral plasma membrane | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 2 | 31 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 1 | 31 |
GO:0042157 | lipoprotein metabolic process | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 4 | 32 |
GO:0035019 | somatic stem cell maintenance | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 3 | 32 |
GO:0005634 | nucleus | 6.35e-02 | 1.00e+00 | 0.663 | 10 | 158 | 3246 |
GO:0006869 | lipid transport | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 34 |
GO:0060041 | retina development in camera-type eye | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 34 |
GO:0045732 | positive regulation of protein catabolic process | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 5 | 35 |
GO:0031124 | mRNA 3'-end processing | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 4 | 35 |
GO:0043434 | response to peptide hormone | 6.78e-02 | 1.00e+00 | 3.836 | 1 | 1 | 36 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 6.97e-02 | 1.00e+00 | 3.796 | 1 | 2 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 4 | 38 |
GO:0006665 | sphingolipid metabolic process | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 1 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 5 | 38 |
GO:0003684 | damaged DNA binding | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 41 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 8.05e-02 | 1.00e+00 | 3.579 | 1 | 2 | 43 |
GO:0003723 | RNA binding | 8.22e-02 | 1.00e+00 | 2.057 | 2 | 22 | 247 |
GO:0006406 | mRNA export from nucleus | 8.23e-02 | 1.00e+00 | 3.546 | 1 | 7 | 44 |
GO:0010467 | gene expression | 8.25e-02 | 1.00e+00 | 1.527 | 3 | 49 | 535 |
GO:0009749 | response to glucose | 8.41e-02 | 1.00e+00 | 3.514 | 1 | 1 | 45 |
GO:0007409 | axonogenesis | 8.41e-02 | 1.00e+00 | 3.514 | 1 | 2 | 45 |
GO:0008013 | beta-catenin binding | 8.41e-02 | 1.00e+00 | 3.514 | 1 | 3 | 45 |
GO:0005654 | nucleoplasm | 8.43e-02 | 1.00e+00 | 1.231 | 4 | 68 | 876 |
GO:0032587 | ruffle membrane | 9.30e-02 | 1.00e+00 | 3.362 | 1 | 3 | 50 |
GO:0060070 | canonical Wnt signaling pathway | 9.48e-02 | 1.00e+00 | 3.333 | 1 | 1 | 51 |
GO:0001822 | kidney development | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 3 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 8 | 52 |
GO:0006302 | double-strand break repair | 9.66e-02 | 1.00e+00 | 3.305 | 1 | 5 | 52 |
GO:0042393 | histone binding | 1.00e-01 | 1.00e+00 | 3.251 | 1 | 3 | 54 |
GO:0000776 | kinetochore | 1.02e-01 | 1.00e+00 | 3.224 | 1 | 8 | 55 |
GO:0008584 | male gonad development | 1.05e-01 | 1.00e+00 | 3.173 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.07e-01 | 1.00e+00 | 3.147 | 1 | 5 | 58 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 5 | 59 |
GO:0009952 | anterior/posterior pattern specification | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 3 | 60 |
GO:0006464 | cellular protein modification process | 1.12e-01 | 1.00e+00 | 3.075 | 1 | 4 | 61 |
GO:0007165 | signal transduction | 1.15e-01 | 1.00e+00 | 1.319 | 3 | 24 | 618 |
GO:0030018 | Z disc | 1.18e-01 | 1.00e+00 | 3.005 | 1 | 3 | 64 |
GO:0005923 | tight junction | 1.18e-01 | 1.00e+00 | 3.005 | 1 | 2 | 64 |
GO:0003676 | nucleic acid binding | 1.21e-01 | 1.00e+00 | 2.961 | 1 | 4 | 66 |
GO:0005515 | protein binding | 1.25e-01 | 1.00e+00 | 0.455 | 11 | 198 | 4124 |
GO:0030308 | negative regulation of cell growth | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 3 | 70 |
GO:0005739 | mitochondrion | 1.33e-01 | 1.00e+00 | 1.226 | 3 | 32 | 659 |
GO:0008289 | lipid binding | 1.33e-01 | 1.00e+00 | 2.816 | 1 | 4 | 73 |
GO:0001649 | osteoblast differentiation | 1.35e-01 | 1.00e+00 | 2.796 | 1 | 5 | 74 |
GO:0005741 | mitochondrial outer membrane | 1.43e-01 | 1.00e+00 | 2.702 | 1 | 2 | 79 |
GO:0030529 | ribonucleoprotein complex | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 5 | 82 |
GO:0044267 | cellular protein metabolic process | 1.48e-01 | 1.00e+00 | 1.546 | 2 | 14 | 352 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.52e-01 | 1.00e+00 | 2.613 | 1 | 5 | 84 |
GO:0030027 | lamellipodium | 1.58e-01 | 1.00e+00 | 2.546 | 1 | 3 | 88 |
GO:0006355 | regulation of transcription, DNA-templated | 1.58e-01 | 1.00e+00 | 1.109 | 3 | 31 | 715 |
GO:0044255 | cellular lipid metabolic process | 1.60e-01 | 1.00e+00 | 2.530 | 1 | 2 | 89 |
GO:0006461 | protein complex assembly | 1.63e-01 | 1.00e+00 | 2.498 | 1 | 2 | 91 |
GO:0000209 | protein polyubiquitination | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0007050 | cell cycle arrest | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 4 | 92 |
GO:0006260 | DNA replication | 1.68e-01 | 1.00e+00 | 2.451 | 1 | 9 | 94 |
GO:0046983 | protein dimerization activity | 1.68e-01 | 1.00e+00 | 2.451 | 1 | 2 | 94 |
GO:0016477 | cell migration | 1.71e-01 | 1.00e+00 | 2.421 | 1 | 3 | 96 |
GO:0008017 | microtubule binding | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 9 | 97 |
GO:0030335 | positive regulation of cell migration | 1.79e-01 | 1.00e+00 | 2.347 | 1 | 2 | 101 |
GO:0043547 | positive regulation of GTPase activity | 1.97e-01 | 1.00e+00 | 2.198 | 1 | 2 | 112 |
GO:0042981 | regulation of apoptotic process | 1.97e-01 | 1.00e+00 | 2.198 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 2.02e-01 | 1.00e+00 | 2.160 | 1 | 8 | 115 |
GO:0005730 | nucleolus | 2.05e-01 | 1.00e+00 | 0.756 | 4 | 74 | 1217 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.22e-01 | 1.00e+00 | 1.173 | 2 | 29 | 456 |
GO:0000398 | mRNA splicing, via spliceosome | 2.22e-01 | 1.00e+00 | 2.005 | 1 | 15 | 128 |
GO:0044212 | transcription regulatory region DNA binding | 2.45e-01 | 1.00e+00 | 1.846 | 1 | 13 | 143 |
GO:0016874 | ligase activity | 2.49e-01 | 1.00e+00 | 1.816 | 1 | 11 | 146 |
GO:0004871 | signal transducer activity | 2.52e-01 | 1.00e+00 | 1.796 | 1 | 4 | 148 |
GO:0008380 | RNA splicing | 2.77e-01 | 1.00e+00 | 1.639 | 1 | 21 | 165 |
GO:0016071 | mRNA metabolic process | 2.84e-01 | 1.00e+00 | 1.596 | 1 | 10 | 170 |
GO:0000166 | nucleotide binding | 2.92e-01 | 1.00e+00 | 1.546 | 1 | 13 | 176 |
GO:0003713 | transcription coactivator activity | 3.04e-01 | 1.00e+00 | 1.482 | 1 | 21 | 184 |
GO:0016567 | protein ubiquitination | 3.09e-01 | 1.00e+00 | 1.451 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 3.09e-01 | 1.00e+00 | 1.451 | 1 | 10 | 188 |
GO:0043065 | positive regulation of apoptotic process | 3.28e-01 | 1.00e+00 | 1.347 | 1 | 7 | 202 |
GO:0006281 | DNA repair | 3.29e-01 | 1.00e+00 | 1.340 | 1 | 24 | 203 |
GO:0008134 | transcription factor binding | 3.37e-01 | 1.00e+00 | 1.298 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 3.39e-01 | 1.00e+00 | 1.291 | 1 | 7 | 210 |
GO:0005813 | centrosome | 3.48e-01 | 1.00e+00 | 1.244 | 1 | 10 | 217 |
GO:0019901 | protein kinase binding | 3.67e-01 | 1.00e+00 | 1.147 | 1 | 8 | 232 |
GO:0007155 | cell adhesion | 3.82e-01 | 1.00e+00 | 1.075 | 1 | 8 | 244 |
GO:0003682 | chromatin binding | 3.92e-01 | 1.00e+00 | 1.028 | 1 | 15 | 252 |
GO:0043565 | sequence-specific DNA binding | 4.19e-01 | 1.00e+00 | 0.902 | 1 | 8 | 275 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.66e-01 | 1.00e+00 | 0.697 | 1 | 17 | 317 |
GO:0044822 | poly(A) RNA binding | 4.68e-01 | 1.00e+00 | 0.363 | 2 | 45 | 799 |
GO:0005829 | cytosol | 4.69e-01 | 1.00e+00 | 0.202 | 4 | 88 | 1787 |
GO:0055085 | transmembrane transport | 4.79e-01 | 1.00e+00 | 0.644 | 1 | 13 | 329 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.91e-01 | 1.00e+00 | 0.592 | 1 | 23 | 341 |
GO:0044281 | small molecule metabolic process | 4.98e-01 | 1.00e+00 | 0.284 | 2 | 35 | 844 |
GO:0045893 | positive regulation of transcription, DNA-templated | 5.27e-01 | 1.00e+00 | 0.447 | 1 | 21 | 377 |
GO:0046872 | metal ion binding | 5.55e-01 | 1.00e+00 | 0.138 | 2 | 24 | 934 |
GO:0006915 | apoptotic process | 5.59e-01 | 1.00e+00 | 0.322 | 1 | 15 | 411 |
GO:0005794 | Golgi apparatus | 5.62e-01 | 1.00e+00 | 0.309 | 1 | 6 | 415 |
GO:0016032 | viral process | 5.74e-01 | 1.00e+00 | 0.264 | 1 | 30 | 428 |
GO:0006351 | transcription, DNA-templated | 6.35e-01 | 1.00e+00 | -0.066 | 2 | 47 | 1076 |
GO:0005887 | integral component of plasma membrane | 6.85e-01 | 1.00e+00 | -0.162 | 1 | 8 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.89e-01 | 1.00e+00 | -0.179 | 1 | 22 | 582 |
GO:0016020 | membrane | 7.00e-01 | 1.00e+00 | -0.232 | 2 | 56 | 1207 |
GO:0005886 | plasma membrane | 7.02e-01 | 1.00e+00 | -0.210 | 3 | 46 | 1784 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.27e-01 | 1.00e+00 | -0.325 | 1 | 29 | 644 |
GO:0005576 | extracellular region | 7.37e-01 | 1.00e+00 | -0.367 | 1 | 15 | 663 |
GO:0008270 | zinc ion binding | 7.70e-01 | 1.00e+00 | -0.500 | 1 | 39 | 727 |
GO:0070062 | extracellular vesicular exosome | 8.54e-01 | 1.00e+00 | -0.675 | 2 | 51 | 1641 |
GO:0016021 | integral component of membrane | 9.61e-01 | 1.00e+00 | -1.570 | 1 | 19 | 1526 |